David J. Wooten

Quantifying Drug Combination Synergy along Potency and Efficacy Axes

Christian T. Meyer, David J. Wooten, B. Bishal Paudel et al. · Cell Systems · 2019 · 231 citations

Medicine, Pharmacology, Pharmacotherapy +13

Systems-level network modeling of Small Cell Lung Cancer subtypes identifies master regulators and destabilizers

David J. Wooten, Sarah M. Groves, Darren R. Tyson et al. · PLoS Computational Biology · 2019 · 119 citations · Full text

Life Sciences, Oncology, Systems Biology +17

MuSyC is a consensus framework that unifies multi-drug synergy metrics for combinatorial drug discovery

David J. Wooten, Christian T. Meyer, Alexander L. R. Lubbock et al. · Nature Communications · 2021 · 109 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Novel Hybrid Phenotype Revealed in Small Cell Lung Cancer by a Transcription Factor Network Model That Can Explain Tumor Heterogeneity

Akshata R. Udyavar, David J. Wooten, Megan Hoeksema et al. · Cancer Research · 2016 · 108 citations · Full text

Medicine, Cancer Biology, Oncology +16

fTPM: A Software-Only Implementation of a {TPM} Chip

Himanshu Raj, Stefan Saroiu, Alec Wolman et al. · USENIX Security Symposium · 2016 · 63 citations

Computing, Computer Engineering, Computer Science +14